{"product_id":"johns-hopkins-wilmer-eye-institute-s-macula-and-the-5th-annual-retina-festival-2025","title":"Johns Hopkins Wilmer Eye Institute’s MACULA and the 5th Annual Retina Festival 2025","description":"\u003cul\u003e\n  \u003cli\u003eTarget Audience: ophthalmologists\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eTarget Audience Specialties – Ophthalmology\u003c\/p\u003e\n\u003cp\u003eOverview\u003c\/p\u003e\n\u003cp\u003eObjectives\u003c\/p\u003e\n\u003cp\u003eExplain the biologic rationale for targeting vascular endothelial growth factors in the treatment of the neovascular form of age-related macular degeneration, diabetic retinopathy, and related diseases.\u003c\/p\u003e\n\u003cp\u003eDiscuss new imaging and therapeutic approaches to diabetic retinopathy, vitreomacular interface abnormalities, intraocular tumors, posterior uveitis, hereditary retinal degenerations, as well as surgical diseases of the retina.\u003c\/p\u003e\n\u003cp\u003eEvaluate recent clinical studies evaluating treatments for retinal degenerations.\u003c\/p\u003e\n\u003ch3\u003eThe Johns Hopkins Wilmer Eye Institute’s MACULA and the 5th Annual Retina Festival 2025 is tailored for:\u003c\/h3\u003e\n\u003cp\u003eOphthalmologists: Specialists interested in the latest advancements in retinal diseases and treatments.\u003c\/p\u003e\n\u003cp\u003eOptometrists: Professionals seeking to deepen their knowledge of macular and retinal care.\u003c\/p\u003e\n\u003cp\u003eOphthalmic Allied Health Professionals: Individuals involved in supporting retinal diagnostics and therapies.\u003c\/p\u003e\n\u003cp\u003eThe event focuses on cutting-edge research, imaging techniques, and therapeutic approaches for retinal diseases.\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eTopics:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e*Note: these are continuous video recordings during the conference, they include individual lectures mentioned in the Detail section below\u003c\/p\u003e\n\u003cp\u003eChoroidal Neovascularization.mp4\u003c\/p\u003e\n\u003cp\u003eContemporary Retinal Imaging.mp4\u003c\/p\u003e\n\u003cp\u003eDiabetic Macular Edema.mp4\u003c\/p\u003e\n\u003cp\u003eGeographic Atrophy And Inhererited Retinal Diseases.mp4\u003c\/p\u003e\n\u003cp\u003eKeynotes.mp4\u003c\/p\u003e\n\u003cp\u003eOcular Tumors.mp4\u003c\/p\u003e\n\u003cp\u003eProliferative Diabetic Retinopathy.mp4\u003c\/p\u003e\n\u003cp\u003eRetinal Vascular Diseases Other than Diabetic Retinopathy.mp4\u003c\/p\u003e\n\u003cp\u003eSpecial Topics in Retina 2025.mp4\u003c\/p\u003e\n\u003ch3\u003e* Detail:\u003c\/h3\u003e\n\u003cp\u003eSaturday, January 11, 2025\u003c\/p\u003e\n\u003cp\u003eWelcome; Conference Goals; Introduction of Keynote Talk\u003c\/p\u003e\n\u003cp\u003eNeil Bressler, MD\u003c\/p\u003e\n\u003cp\u003eWelcome; Conference Goals; Introduction of Keynote Talk\u003c\/p\u003e\n\u003cp\u003eJ. Fernando Arevalo, MD, PhD\u003c\/p\u003e\n\u003cp\u003eKeynote Talk: Global Influence of NIH Funded Retina Networks\u003c\/p\u003e\n\u003cp\u003eDaniel F Martin, MD\u003c\/p\u003e\n\u003cp\u003eContemporary Retinal Imaging – MODERATOR\u003c\/p\u003e\n\u003cp\u003eAmir H Kashani, MD, PhD\u003c\/p\u003e\n\u003cp\u003eContemporary Retinal Imaging – MODERATOR\u003c\/p\u003e\n\u003cp\u003eChristina Y. Weng, MD, MBA\u003c\/p\u003e\n\u003cp\u003eContemporary Retinal Imaging – MODERATOR\u003c\/p\u003e\n\u003cp\u003eJohn B Miller, MD\u003c\/p\u003e\n\u003cp\u003eHome Monitoring for Age-related Macular Degeneration\u003c\/p\u003e\n\u003cp\u003eChristina Y. Weng, MD, MBA\u003c\/p\u003e\n\u003cp\u003eManaging Retina with OCT Angiography\u003c\/p\u003e\n\u003cp\u003eAmir H Kashani, MD, PhD\u003c\/p\u003e\n\u003cp\u003eUltrawide Field Imaging in Diabetic Retinopathy\u003c\/p\u003e\n\u003cp\u003ePaolo S Silva, MD\u003c\/p\u003e\n\u003cp\u003eImaging Geographic Atrophy: Autofluorescence, OCT, Photos\u003c\/p\u003e\n\u003cp\u003eGlenn Jaffe, MD\u003c\/p\u003e\n\u003cp\u003eQuestions and Answers \/ Discussion\u003c\/p\u003e\n\u003cp\u003eGeographic Atrophy and Inherited Retinal Diseases – MODERATOR\u003c\/p\u003e\n\u003cp\u003eDemetrios Vavvas, MD, PhD\u003c\/p\u003e\n\u003cp\u003eGeographic Atrophy and Inherited Retinal Diseases – MODERATOR\u003c\/p\u003e\n\u003cp\u003eMandeep Singh, MD, PhD\u003c\/p\u003e\n\u003cp\u003eGeographic Atrophy and Inherited Retinal Diseases – MODERATOR\u003c\/p\u003e\n\u003cp\u003eStephen Tsang, MD, PhD\u003c\/p\u003e\n\u003cp\u003eTreating Geographic Atrophy: Balancing Benefits and Risks\u003c\/p\u003e\n\u003cp\u003eDemetrios Vavvas, MD, PhD\u003c\/p\u003e\n\u003cp\u003eClinical Trials for Inherited Retinal Diseases\u003c\/p\u003e\n\u003cp\u003eMandeep Singh, MD, PhD\u003c\/p\u003e\n\u003cp\u003eVitamin Supplements for GA or RP: Vitamin A? Not Today\u003c\/p\u003e\n\u003cp\u003eJason Comander, MD, PhD\u003c\/p\u003e\n\u003cp\u003eGene Therapy for Retinal\/Choroidal Vascular Diseases\u003c\/p\u003e\n\u003cp\u003ePeter A Campochiaro, MD\u003c\/p\u003e\n\u003cp\u003eRetinal Vascular Diseases Other Than Diabetic Retinopathy- MODERATOR\u003c\/p\u003e\n\u003cp\u003eAlexander J Brucker, MD\u003c\/p\u003e\n\u003cp\u003eRetinal Vascular Diseases Other Than Diabetic Retinopathy- MODERATOR\u003c\/p\u003e\n\u003cp\u003eJames Handa, MD\u003c\/p\u003e\n\u003cp\u003eRetinal Vascular Diseases Other Than Diabetic Retinopathy- MODERATOR\u003c\/p\u003e\n\u003cp\u003eSunir Garg, MD\u003c\/p\u003e\n\u003cp\u003eMacular Edema from RVO: Does It Matter Which Anti-VEGF\u003c\/p\u003e\n\u003cp\u003eAleksandra Rachitskaya, MD\u003c\/p\u003e\n\u003cp\u003eChallenges of Sickle Cell Retinopathy\u003c\/p\u003e\n\u003cp\u003eJennifer I Lim, MD\u003c\/p\u003e\n\u003cp\u003eTreating MacTel: Just Anatomy or Function Too\u003c\/p\u003e\n\u003cp\u003eEmily Chew, MD\u003c\/p\u003e\n\u003cp\u003eROP and Other Pediatric Retinal Vascular Diseases\u003c\/p\u003e\n\u003cp\u003eYoshihiro Yonekawa, MD\u003c\/p\u003e\n\u003cp\u003eQuestions and Answers \/ Discussion\u003c\/p\u003e\n\u003cp\u003eOcular Tumors\u003c\/p\u003e\n\u003cp\u003eDavid H Abramson, MD\u003c\/p\u003e\n\u003cp\u003eOcular Tumors – MODERATOR\u003c\/p\u003e\n\u003cp\u003eCarol L Shields, MD\u003c\/p\u003e\n\u003cp\u003eOcular Tumors – MODERATOR\u003c\/p\u003e\n\u003cp\u003eIvana Kim, MD\u003c\/p\u003e\n\u003cp\u003eRadiation Retinopathy\u003c\/p\u003e\n\u003cp\u003eArun D. Singh, MD\u003c\/p\u003e\n\u003cp\u003eUpdates on Retinoblastoma and Histiocytosis\u003c\/p\u003e\n\u003cp\u003eJasmine Francis, MD\u003c\/p\u003e\n\u003cp\u003eEvolving Treatments in Choroidal Melanoma\u003c\/p\u003e\n\u003cp\u003eCarol L Shields, MD\u003c\/p\u003e\n\u003cp\u003eOncology Drug Toxicities for the Retina Specialist\u003c\/p\u003e\n\u003cp\u003eWilliam F Mieler, MD\u003c\/p\u003e\n\u003cp\u003eQuestions and Answers \/ Discussion\u003c\/p\u003e\n\u003cp\u003eIntroduction: International Keynote Talk and 100th Celebration\u003c\/p\u003e\n\u003cp\u003eJ. Fernando Arevalo, MD, PhD\u003c\/p\u003e\n\u003cp\u003eIntroduction: International Keynote Talk and 100th Celebration\u003c\/p\u003e\n\u003cp\u003eNeil Bressler, MD\u003c\/p\u003e\n\u003cp\u003eInternational Keynote Talk: AI Revolution in Retina\u003c\/p\u003e\n\u003cp\u003eHaotian Lin, MD, PhD\u003c\/p\u003e\n\u003cp\u003eChoroidal Neovascularization -MODERATOR\u003c\/p\u003e\n\u003cp\u003eLucia Sobrin, MD\u003c\/p\u003e\n\u003cp\u003eChoroidal Neovascularization -MODERATOR\u003c\/p\u003e\n\u003cp\u003eAkrit Sodhi, MD, PhD\u003c\/p\u003e\n\u003cp\u003eChoroidal Neovascularization -MODERATOR\u003c\/p\u003e\n\u003cp\u003eAdam S Wenick, MD, PhD\u003c\/p\u003e\n\u003cp\u003eFixed Dosing, As Needed, or Treat and Extend for CNV\u003c\/p\u003e\n\u003cp\u003eAkrit Sodhi, MD, PhD\u003c\/p\u003e\n\u003cp\u003ePolypoidal Choroidal Vasculopathy: Special Considerations\u003c\/p\u003e\n\u003cp\u003eK. Bailey Freund, MD\u003c\/p\u003e\n\u003cp\u003eSafety Considerations: Inflammation \/ Occlusive Vasculitis\u003c\/p\u003e\n\u003cp\u003eAndre Witkin, MD\u003c\/p\u003e\n\u003cp\u003eQuestions and Answers \/ Discussion\u003c\/p\u003e\n\u003cp\u003eProliferative Diabetic Retinopathy – MODERATOR\u003c\/p\u003e\n\u003cp\u003eK. Bailey Freund, MD\u003c\/p\u003e\n\u003cp\u003eProliferative Diabetic Retinopathy – MODERATOR\u003c\/p\u003e\n\u003cp\u003eJohn Thompson, MD\u003c\/p\u003e\n\u003cp\u003eProliferative Diabetic Retinopathy – MODERATOR\u003c\/p\u003e\n\u003cp\u003eRichard B Rosen, MD\u003c\/p\u003e\n\u003cp\u003eProliferative Diabetic Retinopathy: Anti-VEGF, PRP, or Both\u003c\/p\u003e\n\u003cp\u003eLee M Jampol, MD\u003c\/p\u003e\n\u003cp\u003eEvolving Indications for Surgery in Proliferative DR\u003c\/p\u003e\n\u003cp\u003eDean Eliott, MD\u003c\/p\u003e\n\u003cp\u003eQuestions and Answers \/ Discussion\u003c\/p\u003e\n\u003cp\u003eCurrent Role of Fluorescein Angiography in DME\u003c\/p\u003e\n\u003cp\u003eYannis Mantas Paulus, MD\u003c\/p\u003e\n\u003cp\u003eDiabetic Macular Edema – MODERATOR\u003c\/p\u003e\n\u003cp\u003eMira Sachdeva, MD, PhD\u003c\/p\u003e\n\u003cp\u003eDiabetic Macular Edema – MODERATOR\u003c\/p\u003e\n\u003cp\u003eAllen C Ho, MD\u003c\/p\u003e\n\u003cp\u003eDiabetic Macular Edema – MODERATOR\u003c\/p\u003e\n\u003cp\u003eIshrat Ahmed, MD, PhD\u003c\/p\u003e\n\u003cp\u003eNew Agents for DME: Just Durable or More Durable\u003c\/p\u003e\n\u003cp\u003eJudy E Kim, MD\u003c\/p\u003e\n\u003cp\u003ePort Delivery System Updates for DME\u003c\/p\u003e\n\u003cp\u003eCarl D Regillo, MD\u003c\/p\u003e\n\u003cp\u003eAI in DME: At Its Infancy or A Flash in the Pan\u003c\/p\u003e\n\u003cp\u003eT. Y. Alvin Liu, MD\u003c\/p\u003e\n\u003cp\u003eApproaches to Prevent Worsening of Diabetic Retinopathy\u003c\/p\u003e\n\u003cp\u003eNeil Bressler, MD\u003c\/p\u003e\n\u003cp\u003eQuestions and Answers \/ Discussion\u003c\/p\u003e\n\u003cp\u003eBig Data and Social Determinants of Health in Retinal Diseases\u003c\/p\u003e\n\u003cp\u003eCindy X Cai, MD\u003c\/p\u003e\n\u003cp\u003eSpecial Topics in Retina for 2025 – MODERATOR\u003c\/p\u003e\n\u003cp\u003eLee M Jampol, MD\u003c\/p\u003e\n\u003cp\u003eSpecial Topics in Retina for 2025 – MODERATOR\u003c\/p\u003e\n\u003cp\u003eJoseph Anaya, MD, MBA\u003c\/p\u003e\n\u003cp\u003eSpecial Topics in Retina for 2025 – MODERATOR\u003c\/p\u003e\n\u003cp\u003eJose S Pulido, MD, MPH, Professor\u003c\/p\u003e\n\u003cp\u003ePanel Discussion: Women in Retina in 2025\u003c\/p\u003e\n\u003cp\u003eAdrienne Scott, MD\u003c\/p\u003e\n\u003cp\u003ePanel Discussion: Women in Retina in 2025\u003c\/p\u003e\n\u003cp\u003eJudy E Kim, MD\u003c\/p\u003e\n\u003cp\u003ePanel Discussion: Women in Retina in 2025\u003c\/p\u003e\n\u003cp\u003eJasmine Francis, MD\u003c\/p\u003e\n\u003cp\u003ePanel Discussion: Women in Retina in 2025 – MODERATOR\u003c\/p\u003e\n\u003cp\u003eJennifer I Lim, MD\u003c\/p\u003e\n\u003cp\u003eNew Agents for nAMD: Just Durable or More Durable\u003c\/p\u003e\n\u003cp\u003eSusan Bressler, MD\u003c\/p\u003e\n\u003cp\u003eTherapies for Central Serous Chorioretinopathy\u003c\/p\u003e\n\u003cp\u003eJay Chhablani, MD\u003c\/p\u003e\n\u003cp\u003eSummary: MACULA 2025 and Plans for MACULA 2026\u003c\/p\u003e\n\u003cp\u003eJ. Fernando Arevalo, MD, PhD\u003c\/p\u003e\n\u003cp\u003eSummary: MACULA 2025 and Plans for MACULA 2026\u003c\/p\u003e\n\u003cp\u003eNeil Bressler, MD\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405729386692,"sku":null,"price":52.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/Johns-Hopkins-Wilmer-Eye-Institutes-MACULA-and-the-5th-Annual-Retina-Festival-2025.jpg?v=1784215434","url":"https:\/\/medicalcoursespro.com\/products\/johns-hopkins-wilmer-eye-institute-s-macula-and-the-5th-annual-retina-festival-2025","provider":"Medicalcoursespro","version":"1.0","type":"link"}